Full-Time

Enterprise Business Development Representative

Nursing Health Education

Posted on 11/18/2024

RELX

RELX

1,001-5,000 employees

Provides analytics and decision tools for professionals

Data & Analytics
Social Impact
Legal

Entry, Junior

Company Historically Provides H1B Sponsorship

Florida, USA

Category
Business Development
Business & Strategy
Required Skills
Salesforce

You match the following RELX's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Have excellent written, verbal, and presentation skills, including the ability to communicate complex content to a range of audiences.
  • Possess strong relationship-building skills with customers and internal teams to understand future needs and requirements.
  • Demonstrate proficiency in IT skills and the ability to learn new technology quickly.
  • Motivated self-starter with a positive attitude and a customer-focused approach.
  • Be a team player who enjoys collaborating and solving problems with others.
  • Have proven experience in customer success, account management, or enterprise sales support.
  • Possess strong organizational skills with the ability to manage multiple priorities.
  • Be proficient in CRM software and billing systems.
  • Be detail-oriented with a strong focus on accuracy.
Responsibilities
  • Maintaining customer accounts in Salesforce to ensure accurate information.
  • Collaborating with sales reps and legal teams to expedite contract negotiations and secure necessary approvals.
  • Coordinating with relevant departments to ensure quotes are generated and delivered to customers promptly.
  • Ensuring billing accuracy and timeliness by confirming key invoice details with customers before the scheduled billing date.
  • Facilitating communication and collaboration across departments to enhance the customer experience.
  • Providing support and expertise for special initiatives across the broader team.

RELX provides information-based analytics and decision tools tailored for professional and business customers across various sectors. The company operates in four key areas: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. Its products utilize extensive data and analytics to assist clients, such as researchers, healthcare professionals, legal practitioners, and business executives, in making informed decisions and enhancing productivity. RELX differentiates itself from competitors through its subscription-based business model, which ensures a consistent revenue stream, alongside income from transactional sales and advertising. The company's goal is to support corporate responsibility initiatives, focusing on diversity, social justice, and sustainable development, while actively contributing to the United Nations' Sustainable Development Goals through its offerings.

Company Size

1,001-5,000

Company Stage

IPO

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

1894

Simplify Jobs

Simplify's Take

What believers are saying

  • LexisNexis Risk Solutions' healthcare data simplifies research and accelerates timelines.
  • Elsevier's Reaxys platform integration reduces chemical R&D costs by up to 90%.
  • LexisNexis is recognized as a leader in fraud detection and prevention solutions.

What critics are saying

  • Increased competition in healthcare analytics may impact RELX's market share.
  • Open-access publishing challenges Elsevier's traditional subscription revenue model.
  • Data privacy regulations could increase compliance costs for RELX.

What makes RELX unique

  • RELX offers a subscription-based model ensuring steady recurring revenue streams.
  • The company supports UN's Sustainable Development Goals through its products and partnerships.
  • RELX's diverse client base includes researchers, healthcare professionals, and legal practitioners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Mental Health Support

Family Planning Benefits

Health Savings Account/Flexible Spending Account

Flexible Work Hours

Remote Work Options

Company News

PR Newswire
Jan 29th, 2025
Lexisnexis Risk Solutions Launches Research-Ready Healthcare Data Blends To Expedite Research

Blended, patient-level datasets leveraging proprietary tokenization technology simplify data enrichment while adhering to privacy standards. ATLANTA, Jan. 29, 2025 /PRNewswire/ -- LexisNexis® Risk Solutions, a leading provider of healthcare analytics and insights, today announced the launch of new research-ready, real-world datasets designed to accelerate research timelines, reduce costs and enable more equitable analyses. Using referential-based tokenization, the patient-level datasets are blended, expert determined and certified ensuring they are standardized and research ready. This process gives research teams a more simplified way to enrich their datasets or define a cohort of interest to support specific study objectives, including benchmarking with comparator cohorts. These datasets integrate into clinical research workflows, generating impactful real-world evidence to accelerate innovation and speed-to-market

PharmiWeb
Jan 14th, 2025
Elsevier Appoints Stuart Whayman As President Of Corporate Markets

Mr. Whayman’s previous leadership roles at the company include serving as Chief Financial Officer, Chief Commercial Officer and Managing Director of the Researchers and Librarians business segmentLondon, January 14, 2025. Elsevier, a global leader in scientific information and analytics, announced today the appointment of Stuart Whayman as President of Corporate Markets effective January 6, 2025. Mr. Whayman will report to Kumsal Bayazit, CEO of Elsevier, and will lead the global business that provides advanced scientific and technical information, data and decision support solutions for innovation to R&D-focused organizations across various industries, including pharmaceuticals and chemicals.Mr. Whayman joined Elsevier in 2014, initially as Chief Financial Officer and later served as Chief Commercial Officer

ACN Newswire
Dec 5th, 2024
Shaping Airports For Tomorrow: The 8Th Edition Of Inter Airport Southeast Asia Returns To Singapore In 2025

SINGAPORE, Dec 5, 2024 - (ACN Newswire) - inter airport Southeast Asia, the premier trade exhibition and conference for airport innovation and technology in Asia, will return to Singapore from 25 to 27 March 2025 at the Marina Bay Sands. The 8th edition is expected to bring together over 3,500 representatives of the aviation industry in Asia, influencers in the airports and airlines community, and 150+ exhibitors, including world-class solution providers and airport equipment suppliers, to connect, find synergies, build partnerships, and innovate. As the aviation industry advances and new airport projects and investments surge globally, groundbreaking innovations are essential to drive its transformation. Themed “Airport Operations for Tomorrow” conversations at the exhibition and conference will highlight innovation, technology, and sustainable solutions to optimise terminal and ramp operations of the future. Asia driving majority in airport projects

PharmiWeb
Dec 4th, 2024
Elsevier Adds 43 Million Enamine Make-On-Demand Compounds To Reaxys To Accelerate Chemistry R&D

Access to Enamine’s novel compounds will allow Reaxys users to cut development times and costs by up to 90%​. ​​London, 3 December​ ​2024​ – Elsevier, a global leader in information and analytics, and Enamine, a global leader in supplying small molecules and early drug discovery services, have announced a partnership to integrate Enamine’s database of over 43 million make-on-demand (MADE) analog compounds into Reaxys. The integration will provide chemists with unparalleled access to a diverse array of chemical compounds for accelerated drug discovery and materials science research. Reaxys is a leading chemical database that combines over a billion chemistry data points from scientific journals and patents with AI to support innovation in drug discovery, chemical RD and academia. This new integration combines Enamine's expertise in compound synthesis with the comprehensive capabilities of the Reaxys platform, enabling researchers to access a vast repository of chemical information and facilitating the identification of novel drug targets, biomarkers, and screening compounds

PR Newswire
Oct 30th, 2024
Lexisnexis Risk Solutions Report Reveals How Financial Institutions Are Regaining Visibility Into Consumer Creditworthiness Through Alternative Credit Data

Forty percent of FIs Report Rising Delinquencies Amid Growing Economic Pressure. ATLANTA, Oct. 30, 2024 /PRNewswire/ -- LexisNexis® Risk Solutions unveiled the findings of its inaugural Global Consumer Lending Confidence Report. The study, conducted by Datos Insights, reveals that as visibility into consumer risk provided by traditional credit data shifts, financial institutions worldwide are expanding their use of alternative data throughout the consumer lending journey. Global financial institutions and consumers are navigating economic and regulatory changes. Lenders are seeking more effective ways to predict risk by increasingly turning to alternative credit data to supplement the traditional credit data used by lenders for decades to assess consumer credit risk

INACTIVE